Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Rocket Pharmaceuticals Inc (RCKT)

Rocket Pharmaceuticals Inc (RCKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,509,704
  • Shares Outstanding, K 90,782
  • Annual Sales, $ 0 K
  • Annual Income, $ -245,600 K
  • 60-Month Beta 1.09
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.87
Trade RCKT with:

Options Overview Details

View History
  • Implied Volatility 113.36% ( +10.28%)
  • Historical Volatility 68.59%
  • IV Percentile 99%
  • IV Rank 78.95%
  • IV High 131.39% on 10/02/24
  • IV Low 45.78% on 07/23/24
  • Put/Call Vol Ratio 2.61
  • Today's Volume 101
  • Volume Avg (30-Day) 449
  • Put/Call OI Ratio 0.50
  • Today's Open Interest 9,161
  • Open Int (30-Day) 5,868

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.77
  • Number of Estimates 7
  • High Estimate -0.67
  • Low Estimate -0.84
  • Prior Year -0.75
  • Growth Rate Est. (year over year) -2.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.98 +4.10%
on 10/03/24
22.01 -24.44%
on 09/17/24
-3.10 (-15.71%)
since 09/09/24
3-Month
15.98 +4.10%
on 10/03/24
26.98 -38.36%
on 07/26/24
-4.52 (-21.37%)
since 07/09/24
52-Week
15.98 +4.10%
on 10/03/24
32.53 -48.87%
on 12/28/23
-1.93 (-10.40%)
since 10/09/23

Most Recent Stories

More News
Rocket Pharmaceuticals: Q2 Earnings Snapshot

Rocket Pharmaceuticals: Q2 Earnings Snapshot

RCKT : 16.63 (-3.59%)
Stocks Slide on the Last Trading Day of Q2

The S&P 500 Index ($SPX ) (SPY ) today is down -0.26%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.29%. Stock indexes today are lower...

$SPX : 5,792.04 (+0.71%)
SPY : 577.14 (+0.69%)
$DOWI : 42,512.00 (+1.03%)
DIA : 425.05 (+1.01%)
$IUXX : 20,268.86 (+0.80%)
QQQ : 493.15 (+0.79%)
ZNZ24 : 112-015 (-0.14%)
SYF : 52.00 (+1.58%)
MRVL : 72.84 (-0.37%)
AMD : 171.02 (-1.03%)
NXPI : 238.31 (+1.43%)
KLAC : 804.63 (+2.64%)
Stocks Climb as the Fed’s Favored Inflation Gauge Falls

The S&P 500 Index ($SPX ) (SPY ) today is up +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.33%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.35%. Stock indexes today are moderately...

$SPX : 5,792.04 (+0.71%)
SPY : 577.14 (+0.69%)
$DOWI : 42,512.00 (+1.03%)
DIA : 425.05 (+1.01%)
$IUXX : 20,268.86 (+0.80%)
QQQ : 493.15 (+0.79%)
ZNZ24 : 112-015 (-0.14%)
URI : 813.51 (+1.73%)
HUM : 245.45 (+0.93%)
UNH : 591.22 (+1.66%)
SYF : 52.00 (+1.58%)
TSLA : 241.05 (-1.41%)
Better Gene Editing Stock: Intellia Therapeutics vs. Rocket Pharmaceuticals

Rocket could launch its medicines sooner, but Intellia is aiming for larger markets.

NTLA : 17.65 (-1.34%)
RCKT : 16.63 (-3.59%)
Rocket Pharmaceuticals Stock Is Blasting Off, but Here's Why You Should Tread Carefully

Its near-term risks are subtle but bigger than their flying stock price might indicate.

RCKT : 16.63 (-3.59%)
Betting on Rocket Pharmaceuticals (RCKT)? Check the Options Flow Data First.

Although Rocket Pharmaceuticals lived up to its name on Wednesday due to an encouraging clinical trial development, the big dogs have some questions about RCKT stock.

RCKT : 16.63 (-3.59%)
RCKT|20231020|17.50C : N/A (N/A)
RCKT|20240119|25.00C : N/A (N/A)
Why Shares of Rocket Pharmaceuticals Are Taking Off on Wednesday

The late-stage pharmaceutical company said it had reached an agreement with the Food and Drug Administration regarding a phase 2 trial for a Danon disease therapy.

RCKT : 16.63 (-3.59%)
Stocks Tread Water Before the Open as U.S. Inflation Data Looms

September S&P 500 futures (ESU23) are down -0.02%, and September Nasdaq 100 E-Mini futures (NQU23) are down -0.04% this morning as market participants geared up for a key U.S. consumer inflation report...

ESU23 : 4,491.72s (-0.32%)
NQU23 : 15,435.20s (-0.28%)
ORCL : 178.29 (+2.25%)
AAP : 38.44 (-1.06%)
AAPL : 229.54 (+1.67%)
WRK : 51.51 (+3.54%)
AV-.LN : 480.700 (+0.69%)
WKHS : 0.7669 (+7.65%)
RCKT : 16.63 (-3.59%)
F : 10.62 (+1.24%)
SQSP : 46.50 (+0.04%)
EIGR : 1.7250 (-9.21%)
Rocket Pharmaceuticals Reports First Quarter 2023 Financial Results and Highlights Recent Progress

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare disorders with high unmet need, today...

RCKT : 16.63 (-3.59%)
Rocket Pharmaceuticals to Participate in the Bank of America Securities 2023 Healthcare Conference

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare disorders with high unmet need, today...

RCKT : 16.63 (-3.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Rocket Pharmaceuticals, Inc. is an emerging, clinical-stage biotechnology company. It focused on developing first-in-class gene therapy treatment options for rare, undertreated diseases. Rocket Pharmaceuticals Inc., formerly known as Inotek Pharmaceuticals Corporation, is based in LEXINGTON, United States....

See More

Key Turning Points

3rd Resistance Point 17.86
2nd Resistance Point 17.60
1st Resistance Point 17.11
Last Price 16.63
1st Support Level 16.37
2nd Support Level 16.11
3rd Support Level 15.62

See More

52-Week High 32.53
Fibonacci 61.8% 26.20
Fibonacci 50% 24.25
Fibonacci 38.2% 22.30
Last Price 16.63
52-Week Low 15.98

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar